Showing results 1 to 1 of 1
Title | Author(s) | Issue Date | Views | |
---|---|---|---|---|
LY2874455 and Abemaciclib Reverse FGF3/4/19/CCND1 Amplification Mediated Gefitinib Resistance in NSCLC Journal:Frontiers in Pharmacology | 23-Jun-2022 |
Title | Author(s) | Issue Date | Views | |
---|---|---|---|---|
LY2874455 and Abemaciclib Reverse FGF3/4/19/CCND1 Amplification Mediated Gefitinib Resistance in NSCLC Journal:Frontiers in Pharmacology | 23-Jun-2022 |